Solventum Corp (SOLV) Q2 2025 Earnings Call

Concluded Aug 7, 2025

Aug 7, 2025 0 turns

Period: FY2025 Q2
Runtime: —
Sources: 2 artifacts

8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Separation from 3M and ERP 29 Portfolio optimization 28 2026 guidance and advanced orders 24 Health Information Systems and AI 12 Transform for the Future cost program 10 Q1 results beat expectations 6

Management tone

Confident

Net tone +75 · low hedging

Grounding quotes

“We delivered first quarter results ahead of our plan and ahead of expectations. Organic sales growth and EPS both exceeded our plan”
“Q1 is a clear indication that we are well on our way to delivering our 2026 guidance and, importantly, our go-forward LRP objectives”
“We do see momentum in the business. We do see our growth rate strengthening”
“one should expect that we will accelerate execution of that approval”

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $2.16B +3.8% YoY

Diluted EPS $0.51 +0% YoY

Gross margin 54.4% -0.2 pp YoY

Net income $90.00M +1.1% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 7, 2025 10-Q report Filed Aug 8, 2025

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Med Surg Segment$1.22B +4.8% YoY

Health Information Systems Segment$339.00M +3.4% YoY

Dental Solutions Segment$338.00M +2.1% YoY

Purification and Filtration Segment$189.00M -20.6% YoY

Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →